Wai Yuen Tong Medicine Holdings Dividends and Buybacks
Dividend criteria checks 3/6
Wai Yuen Tong Medicine Holdings is a dividend paying company with a current yield of 12.3%.
Key information
12.3%
Dividend yield
4.3%
Buyback Yield
Total Shareholder Yield | 16.6% |
Future Dividend Yield | n/a |
Dividend Growth | 26.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | HK$0.030 |
Payout ratio | 1,664% |
Recent dividend and buyback updates
Recent updates
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Low P/S No Reason For Excitement
Nov 19Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too
Jul 26Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
Mar 11The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business
Dec 28Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Jul 11Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt
Jul 05Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Mar 08Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now
Aug 18Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Mar 17Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares
Jan 22Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Dec 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 897's dividend payments have been volatile in the past 10 years.
Growing Dividend: 897's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
Wai Yuen Tong Medicine Holdings Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (897) | 12.3% |
Market Bottom 25% (HK) | 3.2% |
Market Top 25% (HK) | 8.0% |
Industry Average (Pharmaceuticals) | 3.7% |
Analyst forecast (897) (up to 3 years) | n/a |
Notable Dividend: 897's dividend (12.3%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.23%).
High Dividend: 897's dividend (12.3%) is in the top 25% of dividend payers in the Hong Kong market (8%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (1663.9%), 897's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (22%), 897's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/28 12:41 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wai Yuen Tong Medicine Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|